The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 151 - 180 of 216 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
|
|
European Medicines Agency's website: Viramune - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Viread - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Virono 50 mg bukkaalitabletti, kiinnittyvä SPC 2024-01-16
|
PL
|
Resepti
|
Visanne 2 mg tabletti SPC 2021-05-28
|
PL
|
Itsehoito
|
Viscotears 2 mg-g silmägeeli SPC 2022-01-24
|
PL
|
Itsehoito
|
Viscotears 2 mg-g silmägeeli, kerta-annospakkaus SPC 2022-01-24
|
PL
|
Resepti
|
Visipaque 270 mg ja 320 mg l-ml injektioneste, liuos, SPC 2022-04-05
|
PL
|
Resepti
|
Visken 15 mg tabletti SPC 00-09-18
|
PL
|
Resepti
|
Visken 5 mg tabletti SPC 00-09-05
|
PL
|
Resepti
|
Vistabel 4 Allergan-yksikköä - 0,1 ml, injektiokuiva-aine, liuosta varten SPC 2022-10-27
|
PL
|
Itsehoito
|
Vistaprep jauhe oraaliliuosta varten SPC 2024-01-31
|
|
|
European Medicines Agency's website: Visudyne - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
VITA-B6 200 mg tabletti SPC 2021-12-29
|
PL
|
Resepti
|
Vitalipid Adult infuusiokonsentraatti SPC 2020-04-14
|
PL
|
Resepti
|
Vitalipid Infant infuusiokonsentraatti, emulsiota varten SPC 2020-06-01
|
PL
|
Resepti
|
Vitaros 2 mg-g (PER), 3 mg-g emulsiovoide SPC 2023-05-09
|
|
|
European Medicines Agency's website: Vitrakvi - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Vivotif enterokapseli, kova SPC 2023-06-30
|
|
|
European Medicines Agency's website: Vizamyl - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Vizarsin - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Vizidor 20 mg-ml silmätipat, liuos SPC 2024-02-27
|
PL
|
Resepti
|
Vizidorduo 20 mg-ml + 5 mg-ml silmätipat, liuos SPC 2024-02-27
|
|
|
European Medicines Agency's website: Vizimpro - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Vobanzl 200 mg infuusiokuiva-aine, liuosta varten SPC 2023-08-01
|
|
|
European Medicines Agency's website: Vocabria - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Vodask 200 mg infuusiokuiva-aine, liuosta varten SPC 2023-06-08
|
|
|
European Medicines Agency's website: Vokanamet - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Volibris - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Voltaren 100 mg peräpuikko SPC 2023-04-11
|
PL
|
Itsehoito
|
Voltaren 140 mg lääkelaastari SPC 2023-04-14
|
|